Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-IPF: Sildenafil in Advanced IPF
NCT00517933Phase 3Completed
- Sponsor
- Duke University
- Start
- Aug 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in idiopathic pulmonary fibrosis (IPF), sponsored by Duke University. Started Aug 2007; status: completed.
02
Drugs
ASP-001
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00517933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517933.